Menu

Blog

Archive for the ‘biotech/medical’ category: Page 417

Sep 16, 2023

Nanomaterials shape and form influences their ability to cross the blood brain barrier

Posted by in categories: biotech/medical, health, nanotechnology, neuroscience

Zhiling Guo, a Research Fellow at the University of Birmingham outlines research into how nanomaterials found in consumer and health-care products can pass from the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape. A new study reveals that this may create potential neurological impacts that could be both positive and negative.

https://www.birmingham.ac.uk/news/latest/2021/07/nanomateria…study.aspx

Sep 16, 2023

Biological Masterpiece — Evolution Wired Human Brains To Act Like Supercomputers

Posted by in categories: biotech/medical, chemistry, evolution, neuroscience, supercomputing

Researchers have confirmed that human brains are naturally wired to perform advanced calculations, similar to e a high-powered computer, to make sense of the world through a process known as Bayesian inference.

In a recent study published in Nature Communications.

<em>Nature Communications</em> is a peer-reviewed, open-access, multidisciplinary, scientific journal published by Nature Portfolio. It covers the natural sciences, including physics, biology, chemistry, medicine, and earth sciences. It began publishing in 2010 and has editorial offices in London, Berlin, New York City, and Shanghai.

Sep 16, 2023

Podcast: Newly approved drug may slow progression of Alzheimer’s

Posted by in categories: biotech/medical, neuroscience

A new episode of our podcast, “Show Me the Science,” has been posted. These episodes feature stories about groundbreaking research, as well as lifesaving and just plain cool stuff involving faculty, staff and students at Washington University School of Medicine in St. Louis.

In this episode, Washington University researchers discuss the Food and Drug Administration’s recent full approval of the drug Leqembi (lecanemab) and what it could mean to the future of Alzheimer’s disease treatments. The drug is approved for use in people with mild dementia from Alzheimer’s disease, but researchers at Washington University’s Charles F. and Joanne Knight Alzheimer Disease Research Center (ADRC), believe the drug, along with other medications in clinical trials, one day may help prevent the development of memory loss and problems with thinking in people who have Alzheimer’s pathology in the brain but who have not yet developed clinical symptoms of the disease.

Barbara Joy Snider, MD, PhD, a professor of neurology and director of clinical trials at the Knight ADRC, says that although Leqembi doesn’t cure Alzheimer’s disease, it slows the decline in memory and thinking, and it also slows the progression of the disorder by removing some amyloid plaques from the brain.

Sep 16, 2023

Antibody Prevents Graft Versus Host Disease in Preclinical Tests

Posted by in categories: biotech/medical, health

Even when a bone marrow transplant cures leukemia or lymphoma, GVHD—in which T cells in the donor graft attack the recipient’s own tissues—can still be fatal. The condition is among the leading causes of death and long-term adverse health consequences associated with bone marrow transplants.

Senior co-corresponding authors Ivan Maillard, MD, PhD, a professor of Medicine and vice chief for research in Hematology-Oncology at the Perelman School of Medicine at the University of Pennsylvania, and Leslie S. Kean, MD, PhD, a professor of Pediatrics at Harvard Medical School and director of Pediatric Stem Cell Transplant at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, along with… More.


In new preclinical research, an experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease in the intestines, without causing broad immune suppression, paving the way for clinical trials.

Continue reading “Antibody Prevents Graft Versus Host Disease in Preclinical Tests” »

Sep 16, 2023

Fiber from crustaceans, insects, mushrooms promotes digestion

Posted by in categories: biotech/medical, cyborgs, food

Digesting a crunchy critter starts with the audible grinding of its rigid protective covering — the exoskeleton. Unpalatable as it may sound, the hard cover might be good for the metabolism, according to a new study, in mice, from Washington University School of Medicine in St. Louis. The researchers, led by Steven Van Dyken, PhD, an assistant professor of pathology & immunology, found in mice that digesting chitin, an abundant dietary fiber in insect exoskeletons and also mushrooms and crustacean shells, engages the immune system. An active immune response was linked to less weight gain, reduced body fat and a resistance to obesity. “Obesity is an epidemic,” Van Dyken said. “What we put into our bodies has a profound effect on our physiology and on how we metabolize food. We’re investigating ways to counteract obesity based on what we learn about how the immune system is engaged by diet.”


Findings, in mice, suggest engaging immune system with such fiber to counteract obesity.

Sep 16, 2023

How Scientists Managed To Transfer “Memories” Between Snails

Posted by in category: biotech/medical

What once was thought to be a Science fiction is now fact which means mind uploading is just around the corner 🤔.


Back in 2018, scientists achieved something that still sounds unbelievable today: they “transplanted” memories from one snail into another. It was a fascinating study in its own right, but it’s also part of a much bigger story: the long-running human quest to understand precisely what memory is and how it works.

How the study worked

Continue reading “How Scientists Managed To Transfer ‘Memories’ Between Snails” »

Sep 16, 2023

AI Chatbots Can Diagnose Medical Conditions at Home. How Good Are They?

Posted by in categories: biotech/medical, robotics/AI

As more people turn to chat-based AIs for medical advice, it remains to be seen how these tools stack up against—or could complement—human doctors.

Sep 15, 2023

Unlocking the Secrets of Aging: Squishy Sea Creature Rewrites Science

Posted by in categories: biotech/medical, life extension, science

Researchers from the National Institutes of Health and their partners have unearthed new findings about healing and aging by studying a tiny sea creature capable of regenerating its entire body using just its mouth. They analyzed the RNA

Ribonucleic acid (RNA) is a polymeric molecule similar to DNA that is essential in various biological roles in coding, decoding, regulation and expression of genes. Both are nucleic acids, but unlike DNA, RNA is single-stranded. An RNA strand has a backbone made of alternating sugar (ribose) and phosphate groups. Attached to each sugar is one of four bases—adenine (A), uracil (U), cytosine ©, or guanine (G). Different types of RNA exist in the cell: messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA).

Sep 15, 2023

Targeted evolution of adeno-associated virus capsids for systemic transgene delivery to microglia and tissue-resident macrophages

Posted by in categories: biotech/medical, evolution, genetics

Cool paper that adds a useful tool to the gene therapist’s toolbox! Young et al. utilize an in vivo screening method to develop adeno-associated viruses (AAVs) which target microglia. They show that their AAVs transduce central nervous system microglia as well as tissue macrophages after intravenous injection. #biotechnology


Tissue macrophages, including microglia, are notoriously resistant to genetic manipulation. Here, we report the creation of Adeno-associated viruses (AAV) variants that efficiently and widely transduce microglia and tissue macrophages in vivo following intravenous delivery, with transgene expression of up to 80%. We use this technology to demonstrate manipulation of microglia gene expression and microglial ablation, thereby providing invaluable research tools for the study of these important cells.

Sep 15, 2023

Scientists identify link between sitting and dementia

Posted by in categories: biotech/medical, neuroscience

New insights into the medical mysteries behind dementia have been revealed this week, with two studies identifying drivers of the brain-degenerating condition.

One study, released on September 11 in the journal General Psychiatry, shows that the shortening of little caps on the end of chromosomes may be linked to increased dementia risk. Another, published in the journal JAMA on September 12, reveals that spending more time sedentary, such as sitting down, may also increase the risk.

These studies may help scientists to further understand the mechanisms behind what causes dementia to develop, and therefore how to stop it.

Page 417 of 2,692First414415416417418419420421Last